Literature DB >> 24262157

Behavioral disorders in Parkinson's disease: the role of dopamine.

Francesca Antonelli1, Antonio P Strafella.   

Abstract

Dopaminergic neurons play a major role in controlling movement and behavior. In Parkinson's disease (PD), dopaminergic denervation is responsible for a number of motor and non-motor symptoms including tremor, rigidity and akinesia and as well apathy, impulsivity and other behavioral complications frequently reported in these patients. In this review, we will summarize the possible proposed dopaminergic mechanisms responsible for these complications in PD, focusing mainly on the role of this neurotransmitter in behavioral symptoms.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Behavioral disorder; Dopamine; Impulsivity; Neuroimaging

Mesh：

Substances：

Year:  2014        PMID： 24262157     DOI： 10.1016/S1353-8020(13)70005-1

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


  9 in total

1.  Risk neurogenes for long-term spaceflight: dopamine and serotonin brain system.

Authors:  N K Popova; A V Kulikov; E M Kondaurova; A S Tsybko; E A Kulikova; I B Krasnov; B S Shenkman; E Yu Bazhenova; N A Sinyakova; V S Naumenko
Journal:  Mol Neurobiol       Date:  2014-08-02       Impact factor: 5.590

Review 2.  Association Between Pathophysiological Mechanisms of Diabetic Retinopathy and Parkinson's Disease.

Authors:  Zhuoqing Zhang; Yikun Zhou; Haiyan Zhao; Jinghui Xu; Xiaochun Yang
Journal:  Cell Mol Neurobiol       Date:  2020-09-03       Impact factor: 5.046

3.  Sodium Butyrate Exacerbates Parkinson's Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model.

Authors:  Chen-Meng Qiao; Meng-Fei Sun; Xue-Bing Jia; Yang Li; Bo-Ping Zhang; Li-Ping Zhao; Yun Shi; Zhi-Lan Zhou; Ying-Li Zhu; Chun Cui; Yan-Qin Shen
Journal:  Neurochem Res       Date:  2020-06-16       Impact factor: 4.414

4.  Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?

Authors:  M A Qamar; A Sauerbier; M Politis; H Carr; P Loehrer; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2017-01-25

Review 5.  Palmitoylation as a Functional Regulator of Neurotransmitter Receptors.

Authors:  Vladimir S Naumenko; Evgeni Ponimaskin
Journal:  Neural Plast       Date:  2018-04-03       Impact factor: 3.599

6.  Impulsivity across reactive, proactive and cognitive domains in Parkinson's disease on dopaminergic medication: Evidence for multiple domain impairment.

Authors:  Nádia Canário; Mário Sousa; Fradique Moreira; Isabel Catarina Duarte; Francisco Oliveira; Cristina Januário; Miguel Castelo-Branco
Journal:  PLoS One       Date:  2019-02-13       Impact factor: 3.240

7.  Neural correlates of working memory and compensation at different stages of cognitive impairment in Parkinson's disease.

Authors:  Takaaki Hattori; Richard Reynolds; Edythe Wiggs; Silvina G Horovitz; Codrin Lungu; Gang Chen; Eiji Yasuda; Mark Hallett
Journal:  Neuroimage Clin       Date:  2022-06-27       Impact factor: 4.891

8.  High reward expectancy during methylphenidate depresses the dopaminergic response to gain and loss.

Authors:  E A Evers; P Stiers; J G Ramaekers
Journal:  Soc Cogn Affect Neurosci       Date:  2017-02-01       Impact factor: 3.436

Review 9.  Early Life Stress, Depression And Parkinson's Disease: A New Approach.

Authors:  Ernest Dallé; Musa V Mabandla
Journal:  Mol Brain       Date:  2018-03-19       Impact factor: 4.041
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.